Trinity Capital, a provider of diversified financial solutions to growth-oriented companies, committed $15 million in growth capital to Velentium, a professional engineering firm that specializes in the design and manufacture of innovative medical devices. The new debt facility from Trinity will facilitate Velentium’s continued growth.
“Velentium brings unique capabilities to their medical device customers and is a trusted partner to help drive new product innovation,” Ryan Kaeding, managing director, life sciences at Trinity, said. “We believe in their team and are excited to help accelerate their growth as a one-stop shop for end-to-end medical device design, development and contract manufacturing.”
“We are thrilled to partner with Trinity as we continue to scale our business and make medical devices safer, more secure and more user-friendly continuing our mission to change lives for a better world through our customer partnerships,” Dan Purvis, CEO of Velentium, said.
